Skip to main content

Table 1 Sample characteristics

From: Posttraumatic growth and well-being among adolescents and young adults (AYAs) with cancer: a longitudinal study

  Respondents with at least 2 follow-up questionnaires completed
N = 169 (78.6%)a 		Non-respondents at follow-up
N = 18 (8.4%) 		Deceased at follow-up
N = 28 (13.0%) 		p value
Sex     0.09
 Female 77 (45.6%) 6 (33.3%) 18 (64.3%)  
 Male 92 (54.4%) 12 (66.7%) 10 (35.7%)  
Race     0.58
 White 77 (46.1%) 7 (38.9%) 11 (39.3%)  
 Hispanic/Latino 72 (43.1%) 8 (44.4%) 11 (39.3%)  
 Other 18 (10.8%) 3 (16.7% 6 (21.4%)  
Relationship statusb     0.13
 No 108 (65.1%) 8 (44.4%) 14 (51.9%)  
 Yes 58 (34.9%) 10 (55.6%) 13 (48.1%)  
Educational level     0.06
 Less than high school 86 (51.5%) 6 (33.3%) 10 (35.7%)  
 High school graduate 22 (13.2%) 4 (22.2%) 5 (17.9%)  
 Some college 34 (20.4%) 7 (38.9%) 4 (14.3%)  
 College graduate or above 25 (15.0%) 1 (5.6%) 9 (32.1%)  
Employment/school status     0.90
 Not occupiedc 98 (59.0%) 10 (55.6%) 15 (62.5%)  
 Occupiedd 68 (41.0%) 8 (44.4%) 9 (37.5%)  
Age at diagnosis, years     0.012
 Mean (SD)     
 14–17 79 (46.7%) 4 (22.2%) 5 (17.9%)  
 18–25 33 (19.5%) 3 (16.7%) 7 (25.0%)  
 26–39 57 (33.7%) 11 (61.1%) 16 (57.1%)  
Type of cancer     0.003
 Breast carcinoma 15 (8.9%) 1 (5.6%) 3 (10.7%)  
 Hodgkin lymphoma 20 (11.8%) 3 (16.7%) 0 (0%)  
 Non-Hodgkin lymphoma 13 (7.7%) 2 (11.1%) 2 (7.1%)  
 Testicular carcinoma 8 (4.7%) 5 (27.8%) 1 (3.6%)  
 Female reproductive 3 (1.8%) 2 (11.1%) 3 (10.7%)  
 Soft tissue sarcoma 19 (11.2%) 0 (0%) 2 (7.1%)  
 Brain 13 (7.7%) 0 (0%) 1 (3.6%)  
 Leukemia 44 (26.0%) 1 (5.6%) 5 (17.9%)  
 Bone tumors 21 (12.4%) 1 (5.6%) 4 (14.3%)  
 Other carcinomase 13 (7.7%) 3 (16.7%) 7 (25.0%)  
Severity of cancer by survival rate     0.03
 <50% 53 (31.4%) 1 (5.6%) 9 (32.1%)  
 50–80% 68 (40.2%) 6 (33.3%) 13 (46.4%)  
 >80% 48 (28.4%) 11 (61.1%) 6 (21.4%)  
Type of treatment     
 Receiving chemotherapy 147 (87.0%) 9 (52.9%) 19 (67.9%) <0.001
 Receiving radiation 29 (17.2%) 5 (29.4%) 3 (10.7%) 0.27
 Surgical treatment 51 (30.2%) 4 (23.5%) 11 (39.3%) 0.50
Treatment status baseline     0.017
 Off treatment 9 (5.3%) 4 (22.2%) 4 (14.3%)  
 On treatment 160 (94.7%) 14 (77.8%) 24 (85.7%)  
  1. aFor some variables, the sum of number is not 169 because of missing data
  2. bQuestion was worded as follows: “Are you currently married, living together, or in a significant committed relationship?”
  3. cResponse categories included the following: on temporary medical leave/disability, unemployed, and permanently unable to work
  4. dResponse categories included the following: employed full time, employed part time, full-time homemaker, and full-time student
  5. eOther carcinomas included thyroid, melanoma, adrenocortical carcinoma, hepatic carcinoma, colorectal carcinoma, head and neck cancer, and other sarcoma
Back to article page